Bank Of New York Mellon Corp Oncorus, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.24 - $0.76 $15,959 - $50,538	66,498 New	66,498 $16,000
Q3 2022 Nov 14, 2022	SELL	$0.85 - $1.65 $25 - $49	-30 Reduced 0.04%	66,995 $57,000
Q2 2022 Aug 15, 2022	SELL	$1.04 - $1.86 $57,222 - $102,340	-55,022 Reduced 45.08%	67,025 $84,000
Q1 2022 May 11, 2022	BUY	$1.44 - $5.62 $90,698 - $353,975	62,985 Added 106.64%	122,047 $218,000
Q4 2021 Feb 11, 2022	BUY	$5.03 - $11.63 $5,361 - $12,397	1,066 Added 1.84%	59,062 $312,000
Q3 2021 Nov 12, 2021	BUY	$9.29 - $14.27 $74,868 - $115,001	8,059 Added 16.14%	57,996 $542,000
Q2 2021 Aug 11, 2021	BUY	$13.3 - $17.3 $428,153 - $556,921	32,192 Added 181.41%	49,937 $689,000
Q1 2021 May 13, 2021	BUY	$11.89 - $35.55 $3,293 - $9,847	277 Added 1.59%	17,745 $247,000
Q4 2020 Feb 09, 2021	BUY	$15.0 - $35.15 $262,020 - $614,000	17,468 New	17,468 $564,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.